The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, however its legacy within the broader market now triggers questions about potential returns . Alternative versions are undercutting market share, causing concerns that investing in companies heavily reliant to Viagra's former standing could be a problema